dumbmrblah

12 ms·

1. 91.▲
   by dumbmrblah 4y ago

   The next generation CAR-T treatments are supposed to be "easier" on the immune system and hopefully don't require the prolonged hospitalizations. But that is 5-10 years away.
2. 92.▲
   by dumbmrblah 4y ago

   I responded to another post similar down but you are correct. The drug is $500k, the surrounding medical care / hospitalizations etc pushes the total cost to over $1,000,000
3. 93.▲
   by dumbmrblah 4y ago

   Good question and I should have been more clear. The drug itself is $300,000-$500,000. It’s crazy expensive, but it’s not like a hedge fund patenting 100 year old insulin or something, it’s a bespoke medication. I still think they are pri
4. 94.▲
   by dumbmrblah 4y ago

   Incorrect. Yescarta, Tecartus among others are approved for certain types of lymphoma. Multiple myeloma has Carvykti and Abecma https://www.cancer.gov/sites/g/files/xnrzdm211/files/styles/...
5. 95.▲
   by dumbmrblah 4y ago

   MD and I work in the field. The technology is called CAR-T, as the article mentioned. It’s been used pretty widely for “liquid” tumors for a while (eg leukemia, lymphoma, and multiple myeloma),but solid tumors are particularly difficult to
6. 96.▲
   by dumbmrblah 4y ago

   I've lived in NYC, SF, Boston, even Baltimore. SF was the only place I have ever felt unsafe. I live on the 'wrong side of MLK' in Baltimore for a bit, never had a problem even with open air drug dealers on my block. SF da